1. Profile

Arab Drug Co

Last Updated:
  • 137.25 EGP
  • -0.01
  • -0.01%
العربية للأدوية والصناعات الكيماوية
أدكو
Symbol : ADCI
ISIN : EGS38321C013
52-Week Range : 70.00 - 148.00
Turnover Ratio : 0.09
Market : Egyptian Exchange
Sector : Health Care & Pharmaceuticals
Industry : Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :

Basic Information

  • Activity :
    Arab Pharmaceuticals (known as: ADCO) is a public company, listed on Egyptian Exchange (EGX) since February 1996. It operates within the pharmaceuticals, biotechnology & life sciences sector focusing...
  • Industry Group :
    pharmaceuticals Research and Biotechnology
  • Sub-Industry :
  • ISIN :
    EGS38321C013
  • Contact Person :
    Mohsen El Nady
  • Established On:
    20-Jul-1991
  • Stock Listing On :
    06-Feb-1996
  • No of Employees :
    947 Employees as of 2024
  • Outstanding Shares :
    6,000,000
  • Free Float Shares :
  • Par Value :
  • Paid Capital :
  • Market Cap :
  • Authorized Capital :

Indices Membership

Action Date Index Provider
Join 2020 Health Care & Pharmaceuticals Egyptian Exchange
Join 1996 Egyptian Exchange
Arab Drug Co
5 Al Masanie St., Amiriya, Cairo
T : +20 2 22822113
F : +20 2 22832614
www.adcopharma-eg.com
info@adcopharma-eg.com

Management

Title Name As Of
Chairman: Mahmoud Hamdi
CEO: Tamer Al Husseini
Board Member: Maher Makar 2021
Nevin Jaber 2021
Faten Fathallah 2024
Yousry Nawar
Essam Eddin Ramadan

Reports

Date Title File
2024 ADCO Quarterly Financials Report Q1 2025
2024 ADCO Annual Financials Report 2024
2024 ADCO Quarterly Financials Report Q3 2024
2024 A statement from the company regarding the company’s regulatory framework
2024 ADCO Quarterly Financials Report Q2 2024
2023 ADCO Quarterly Financials Report Q3 2023
2023 ADCO Annual Financials Report 2023
2023 ADCO Quarterly Financials Report Q3 2023
2023 ADCO Quarterly Financials Report Q2 2023
2022 ADCO Quarterly Financials Report Q1 2023
2022 ADCO Annual Financials Report 2022
Check our coverage for
Check The List